Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

Abstract Background A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare subtype of invasive adenocarcinoma of the lung. The prognosis of advanced IMA depending on chemotherapy regimen has not been fully investigated. Here, we compared the clinical outcomes of patients with advanced...

Full description

Bibliographic Details
Main Authors: Yoon Jung Jang, Dong-gon Hyun, Chang-Min Choi, Dae Ho Lee, Sang-We Kim, Shinkyo Yoon, Woo Sung Kim, Wonjun Ji, Jae Cheol Lee
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Cancer
Subjects:
Adenocarcinoma of the lung
Mucinous
Stage IV
Prognosis
Treatment outcome
Online Access:https://doi.org/10.1186/s12885-021-08472-6

Internet

https://doi.org/10.1186/s12885-021-08472-6

Similar Items